LAG3 and non-small cell lung carcinoma: LAG-3-expressing tumors are usually associated with poor survival, although a high expression of LAG-3 is associated with favorable overall survival and disease-free survival in some solid tumors, particularly in early-stages, such as breast cancer, ENKTL nasal type, NSCLC, and TNBC [88].